Joseph D Khoury Selected Research

Joseph D Khoury Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 05/2002
20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2014
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2017
10	Lymphoma (Lymphomas) 01/2021 - 05/2002
9	Philadelphia Chromosome 01/2021 - 11/2015
8	Disease Progression 01/2022 - 04/2007
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 11/2016
7	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2020 - 09/2003
6	Leukemia 01/2022 - 11/2018
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 11/2015
4	Infections 12/2018 - 11/2015
3	Primary Myelofibrosis (Myelosclerosis) 02/2022 - 10/2015
3	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2022 - 01/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 12/2020
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 03/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
3	Hodgkin Disease (Hodgkin's Disease) 12/2020 - 01/2017
3	Pathologic Complete Response 07/2020 - 11/2015
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 01/2003
3	Splenomegaly 01/2018 - 09/2016
2	Thrombocytopenia (Thrombopenia) 06/2022 - 01/2018
2	Necrosis 06/2021 - 01/2010
2	Lymphadenopathy 02/2021 - 01/2016
2	Plasmablastic Lymphoma 01/2021 - 08/2015
2	Hairy Cell Leukemia 10/2020 - 11/2018
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2020 - 01/2019
2	Pancreatitis 12/2018 - 11/2015
2	Hypertension (High Blood Pressure) 12/2018 - 11/2015
2	Exanthema (Rash) 12/2018 - 11/2015
2	Myocardial Infarction 12/2018 - 11/2015
2	Fibrosis (Cirrhosis) 01/2018 - 10/2015
2	Retinoblastoma (Glioblastoma, Retinal) 12/2017 - 03/2009
2	Breast Neoplasms (Breast Cancer) 03/2015 - 01/2010
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2014 - 03/2014
2	Circulating Neoplastic Cells 12/2010 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 12/2010 - 01/2010
2	Melanoma (Melanoma, Malignant) 08/2010 - 08/2009
2	Osteosarcoma (Osteogenic Sarcoma) 09/2008 - 07/2006
2	Neuroblastoma 01/2008 - 12/2007
2	Genetic Translocation (Chromosomal Translocation) 01/2008 - 07/2005
2	Rhabdomyosarcoma 09/2006 - 05/2006
2	Ewing Sarcoma (Sarcoma, Ewing) 07/2006 - 07/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2016
5	Cyclin D1IBA 01/2022 - 01/2003
5	venetoclaxIBA 01/2022 - 01/2019
5	Biological ProductsIBA 10/2021 - 09/2007
4	Vincristine (Oncovin)FDA LinkGeneric 10/2021 - 11/2015
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2005
3	Transaminases (Aminotransferases)IBA 06/2022 - 01/2018
3	fms-Like Tyrosine Kinase 3IBA 01/2022 - 12/2017
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 09/2006
3	Rituximab (Mabthera)FDA Link 10/2021 - 04/2017
3	ponatinibIBA 01/2021 - 11/2015
3	ChromatinIBA 01/2021 - 05/2002
3	Reticulin (Reticular Fiber)IBA 01/2018 - 10/2015
3	ParaffinIBA 01/2010 - 09/2003
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2022 - 11/2015
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2009
2	Azacitidine (5 Azacytidine)FDA Link 01/2022 - 12/2017
2	c-Mer Tyrosine KinaseIBA 01/2022 - 01/2021
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021 - 01/2021
2	S100 Proteins (S 100 Protein)IBA 06/2021 - 01/2019
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 10/2015
2	Inotuzumab OzogamicinIBA 01/2021 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 08/2009
2	ofatumumab FDA Link 01/2021 - 07/2020
2	blinatumomabIBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2017
2	LigandsIBA 01/2020 - 01/2020
2	CateninsIBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 12/2018 - 11/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2018 - 02/2017
2	CollagenIBA 10/2015 - 09/2007
2	RNA (Ribonucleic Acid)IBA 08/2015 - 08/2013
2	fibrin fragment D (D-dimer)IBA 03/2015 - 12/2010
2	Imatinib Mesylate (Gleevec)FDA Link 03/2014 - 11/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2010 - 01/2010
2	ErbB Receptors (EGF Receptor)IBA 09/2008 - 09/2006
2	Formaldehyde (Formol)FDA Link 08/2005 - 09/2003

Therapy/Procedure

52	Therapeutics 01/2022 - 04/2004
17	Drug Therapy (Chemotherapy) 10/2021 - 04/2007
9	Radiotherapy 10/2021 - 07/2006
3	Breast Implants (Breast Implant) 04/2020 - 06/2018
3	Consolidation Chemotherapy 01/2020 - 01/2018
3	Precision Medicine 11/2019 - 01/2016
2	Hematopoietic Stem Cell Transplantation 02/2022 - 11/2018
2	Salvage Therapy 01/2021 - 03/2009
2	Aftercare (After-Treatment) 10/2020 - 07/2006
2	Stem Cell Transplantation 07/2020 - 11/2018
2	Immunotherapy 01/2020 - 01/2020
2	Castration 12/2010 - 01/2010